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“History of the Opioid Epidemic” 


















 Drug abuse, addiction, and overdoses are phenomenon’s that are not new or unfamiliar to 
the United States. Between 1999 to 2017, there were over 700,000 drug overdose deaths in the 
country. About 400,000 of those drug overdoses involved an opioid. In 2017, more than 70,000 
people died of a drug overdoses and 68% of them involved an opioid. This makes the number of 
opioid drug overdose deaths in 2017 six times higher than in 1999 (Center for Disease Control 
and Prevention, 2018). The severity of the increase in opioid related overdose deaths that 
America is experiencing today did not happen randomly. The growing number of citizens who 
are addicted to opioids and overdosing on them has become a cause for concern for citizens, 
public officials, and government agencies. In 2016, a Kaiser Family Foundation poll found that 
56% of Americans knew someone who abused, was addicted to, or died from an opioid overdose 
(Dijulio, Firth, Hamel, & Brodie, 2015). 
The opioid epidemic in the United States has a long history beginning in the mid-1990s. 
When attempting to understand why the United States is facing this crisis it’s necessary to dive 
deep into the history of how opioids have become prominent all over the country. This epidemic 
did not happen overnight – quite the opposite. It has been a long and painful journey of 
addiction, pain, and death. This paper is intended to dig into the history of the opioid epidemic in 
America and explain how it came to be declared a public health emergency by our government in 
2017 (Jones, 2018). An epidemic that is unique to the United States, it is worth analyzing what 
differs in American history that led to an epidemic that kills an average of 130 Americans per 






Brief History of Opium 
Opioids and heroin derive from an addictive substance called opium. Opium abuse has 
had an extensive history across the world, its earliest recordings dating to 3,400 B.C. in 
Southwest Asia (DEA Museum, 2019). The popularity of the drug and its effects passed on to 
other countries, and there was soon a growing demand for opium and morphine (another 
powerful opium drug). After making its way to China, the drug became the catalyst for two wars 
between China and Britain in the 19th century. In 1853, Dr. Alexander Wood, the Scottish 
inventor of the hypodermic needle, believed that smoking or swallowing morphine was the cause 
for addiction, whereas intravenous injection would provide a loophole. During the Civil war in 
the 1860s, injecting opium became common to use on soldiers who had been hurt to treat pain. 
Opium addiction became particularly severe among white Southerners in small towns and cities 
where heartbroken family members turned to opium to deal with losing their loved ones and 
economic despair brought on by the abolition of slavery (Macy, 2018). 
Despite its popularity during this time, there were a few doctors who sounded the alarm 
on opium and morphine addiction and argued for stricter regulations. In 1884, the Virginia 
General Assembly considered placing regulations on prescribed opium and morphine due to 
pleas from a Richmond doctor W.G. Rogers The legislature decided against approving the bill to 
regulate these addictive substances (Macy, 2018). With acceptance and demand for opium 
growing, it is of no surprise that the invention of heroin in 1898– a drug already ten times 
stronger than opium – was a booming success. By 1900, more than 250,000 Americans were 





Opioids in the United States 
In 1924, twenty-six years after the release of heroin, the manufacture of the drug was 
outlawed in the US with the passing of the Heroin Act (Jones et al., 2018). Having already 
become addicted to the substance, many heroin users were forced to turn to the illegal drug 
market to purchase the drug. This event marked a turning point in how addicted persons were 
classified in the public eye. Before outlawing heroin, iatrogenic addicted opioid users were more 
common and not as publicly detested. Heroin users were now referred to as “junkies” and society 
cast them to the side. As government officials began enforcing these regulations, some began to 
view heroin users as criminal. The population of opioid and heroin addicted people was 
neglected by most of society during this time. This trend continued until recent years, where 
opioid addicted persons may now be viewed again as addicts in need of treatment and recovery. 
Although evidence existed against opioids and its addictive qualities, opioid prescription 
pills were sometimes prescribed by doctors in the United States. However, until the release of 
two retrospective publications that argued opioid addiction was rare, using opioids to treat pain 
was vastly limited in the medical industry. In 1980, an article was published describing low 
(0.03%) addiction rates for inpatients receiving opioids for acute pain (Jones, 2018). Six years 
later in 1986, another article was released claiming that in a study done on 38 patients, only 2 of 
38 patients with chronic pain developed misuse or abuse issues when receiving opioids 
(Portenoy & Foley, 1986). The scientific rigor of these studies has since been questioned and 
discredited a great deal.  
After these publications, The World Health Organization addressed the under-treatment 
of postoperative and cancer pain in 1986 with their Cancer Pain Monograph – detailing how 
cancer pain relief has been neglected among the medical and public health communities (WHO, 
8 
 
1986). Shortly after in 1990, an article published in a scientific journal questioned why opioids 
were only prescribed to treat cancer-related pain and avoided entirely non-cancer chronic pain 
states (Melzack, 1990). The study prompted interests that were based on fallacies, drawn mainly 
by cancer pain specialists lacking expertise on other chronic, non-cancer pain (Jones, 2018). 
In 1995, the American Pain Society announced a presidential address and launched an 
influential campaign called “pain as the fifth vital sign”. The campaign advocated for proper, 
standardized evaluations and treatments of pain (Campbell, 1995). The Veterans Health 
Administration lent support to the campaign in 1999 (Jones, 2018). By 1999, 86% of patients 
using opioids in America were using them for non-cancer pain (Lui, Pei, & Soto, 2018). The 
following year, the Joint Commission (TJC) published standards for pain management, 
emphasizing the need for organizations to conduct quantitative assessments of pain. The nation 
continued responding well to these efforts. In 2002, the Federation of State Medical Boards and 
the Drug Enforcement Agency issued statements promising less regulatory scrutiny over opioid 
prescribers, thereby reducing physician’s reluctance to prescribe more liberal amounts of opioid 
pills (Joranson, 2002). 
  After the medical industry began developing a new standard for pain assessment and 
pain treatment. This movement led to doctors and nurses being economically incentivized to treat 
pain more liberally and it shifted the thinking towards patients as health care consumers. 
Pharmaceutical companies heavily pushed the use of opioids as a humane treatment option, often 
using paid physician consultants to expound on the safety and benefits of opioids use (Jones, 
2018). Since the beginning of the pain movement, the rate of opioid prescription use in the US 
has skyrocketed.  
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From 1999 to 2011, consumption of hydrocodone more than doubled and consumption of 
oxycodone increased by nearly 500%. From 1997 to 2011, there was a 900% increase in 
individuals seeking treatment for addiction to opioid pain relievers (Kolodny et al., 2015). With 
the surges in opioid distribution and opioid addicted persons seeking treatment, it is of no 
surprise that a drastic increase in fatal opioid-related drug overdoses occurred during the same 
time. The shocking correlation between the three statistics can be shown in the chart below;  
 
*Source: (Kolodny et al., 2015) 
This chart illustrates the rate of opioid sales, opioid deaths, and opioid treatment admissions 
between 1999 and 2010 (Kolodny et al., 2015). This chart confirms the direct relationship 
between opioid overdoses and the medical industry’s production of opioid prescription pills. The 
graph implies that as the number of opioids being sold or prescribed increases, the number of 
people becoming addicted to the substance and overdosing on it also increases. A large 
contributor to the number of opioids being sold, a prescription opioid known as Oxycontin was 




Oxycontin and Purdue Pharmaceutical  
 In a remote western corner of Virginia, Lee County was home to the introduction of the 
opioid painkiller known as OxyContin and was a hot spot for the plethora of other opioid pills 
that hit the nation beginning in the mid-1990s. Although the opioid epidemic has impacted every 
part of America, this area in the former mill and mining communities of central Appalachia is 
important to mention because it was impacted more severely than other communities. Lee 
County the area where OxyContin was introduced, and it was a hotspot for a plethora of other 
opioid painkillers. The overdose rate for this part of the country in 2015 was approximately 65% 
higher than the rest of the country (Macy, 2018).  
 Oxycontin was originally created by a small family-owned pharmaceutical company 
called Purdue Pharmaceutical, based in Stamford, CT. The pill was approved by the Food and 
Drug administration in 1995, despite its potentially addictive qualities that were overlooked due 
to the pain movement. Purdue Pharma’s pain specialist, Dr. J. David Haddox, made claims that 
taking Oxycontin as prescribed puts the risk of addiction at one-half of one percent and that 
iatrogenic (or doctor caused) addictions were very rare (Meier, 2003). However, there were 
accounts of police lieutenants in Lee County already sounding alarms regarding opioid addiction 
in 1997 (Macy, 2018). Only two years into its release, officials and police officers in the area 
were beginning to see the death, pain, and devastation that Oxycontin could cause.  
 Now that many actors in the medical industry were encouraged to dispense opioids to any 
patient experiencing serious pain, Purdue Pharma and other large pharmaceutical companies, 
began seeing the large financial profit that could be gained from the sale of their opioid pills. 
Between 1995 and 1998, drug advertising expenses increased from $360 million to $1.3 billion. 
During this time, Purdue Pharma reps began visiting small rural Virginia towns and offering an 
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overabundance of incentives to doctors who prescribed more OxyContin to their patients. In 
2000, pharmaceutical companies spent $4.04 billion in direct marketing to doctors, a 64% 
increase from 1996 (Macy, 2018). During an interview with a former Purdue Pharma sales 
representative in January 2017, journalist Beth Macy accounts that the Purdue Pharma rep 
claimed doctors were offered more incentives the higher the milligrams prescribed. In the 
interview he also stated, “the doctors they incentivized were handpicked, based on certain 
predictors such as patient volume and past prescribing history” (Macy, 2018). The efforts of 
these companies led to local family doctors being the single largest group of prescribers during 
this time (Tough, 2001). While sales representatives’ bonuses continued to grow, the population 
was quickly becoming addicted to a substance that would lead to thousands of overdoses and 
deaths.  
As history repeated itself, there was a growing cause of concern for residents and medical 
officials regarding the increasing distribution of Oxycontin. In 2001, a study was released that 
was conducted by the Roanoke based medical examiner regarding Oxycontin overdose deaths. 
The study found that in Roanoke in1997 Oxycontin was responsible for one death, the following 
year it was responsible for three deaths, and the year after it was responsible for sixteen deaths 
(Bowman, 2001). This study was not released until 2001, five years after the introduction of 
Oxycontin, and after a massive number of people were already addicted. By this time, there were 
43 overdose deaths for the region. As more people began realizing that opioids were responsible 
for so many overdose deaths, some began to fight against opioids, with most of their cries going 





The Legal Battle 
Despite frustrations of being disregarded by so many agencies, doctors and other citizens 
who agreed with their dispute against prescribing opioids so freely, continued to raise the issue 
of Oxycontin. In 2001, the public began their legal fight with multiple different government 
agencies and officials including the FDA and Purdue Pharma, attempting to reduce the 
prescribing of the drug. In 2003, doctors and other members of the community – distraught by 
what they were seeing – created a group called Relatives Against Purdue Pharma (RAPP). The 
group worked to dig into the legalities of the distribution of Oxycontin. After a long wait, civil 
charges were finally brought against the company in 2003 (Macy, 2018).  
 Criminal justice sectors also decided to bring criminal and civil charges against various 
pharmaceutical companies that were responsible for so much harm. In 2006, the department of 
justice brought criminal charges against Purdue Pharma. The company was accused of 
undermining the risks of using opioids and misleading the health industry regarding the benefits 
of using opioids to treat chronic pain. To the disappointment of the community, there were 
minimal criminal charges brought against members of Purdue. The company was instead ordered 
to pay severe fines – a total of $634.5 million – for misleading the public (Meier, 2019). 
However, after the devastation and loss that thousands of wives, mothers, fathers, and friends 
had experienced due to Oxycontin, the penalties that Purdue Pharma faced seem extremely 
miniscule. 
 The battle against large pharmaceutical companies is still ongoing today. In 2019, some 
states are continuing their fight against the company. Massachusetts has brought charges against 
members of the Sackler family – members on the board of Purdue Pharmaceutical – accusing 
them of putting patients on higher dosages of Oxycontin, knowing it increased the risk of serious 
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side effects, such as addiction. The family profited directly from the sale of Oxycontin, and they 
have been named one of the richest families in the country (Meier, 2019). The Massachusetts 
attorney general estimated that from 2008 to 2016 the company profited over four billion dollars. 
 In March 2019, Purdue Pharma agreed to pay a $270 million-dollar settlement to the state 
of Oklahoma for the damage caused by their company (Hill, 2019). There has been rumors of the 
company filing for bankruptcy. Currently, more than 1,600 lawsuits in federal and state courts 
have been brought against large pharma companies to place blame for the opioid epidemic. The 
continuing legal fight against these companies reveals the country’s strong desire to receive 
justice for the desolation the opioid crisis has caused.  
Opioid Overprescribing Policies 
After the case against Purdue Pharma, strict regulations were put on doctors and 
pharmaceutical companies to prevent the overprescribing and misuse of opioids. The list of state 
policies that have been implemented to limit the harm of opioid addiction is an extensive one. 
Almost every state has adopted some type of policy or intervention that is intended to stop opioid 
overprescribing. There are a few types of strategies that are used in opioid overprescribing; 
1. Prescribing limits and guidelines: Restrictions based on the quantity of pills and/or 
number of days prescribed.  
2. Mandatory prescription monitoring: Regulations mandating the close monitoring of 
persons receiving opioid prescriptions.   
3. Standards of care: Offering the best care and treatment to patients suffering from opioid 
use disorder.  
4. Prescriber education: Mandates continuing education of doctors, nurses, physicians, and 
any other medical workers who can prescribe opioids.   
The implementation of these policies has led to a decline in opioid prescriptions across the nation 
(Pryor, 2017). The policies imply that many state governments and agencies believe combating 
overprescribing begins with the medical officials that are doing the prescribing.  
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Opioid prescribing policies are intended to reduce harm and death caused by opioid 
prescription pills and pharmaceutical companies. The logic behind these policies believes that 
with a decrease in the prescribing of opioid pills, overdose deaths and addiction would also 
decline. However, with a large portion of the US population already addicted to the drug, it was 
estimated that in 2014 prescription opioids were still the direct cause of approximately 29,000 
overdose deaths (Kahler et al., 2017). Unfortunately, not only have these policies failed in their 
goal of reducing opioid abuse and overdoses, the implementation of these policies has had some 
negative impacts on the opioid epidemic. These unintended consequences are essential to note 
when discussing the history of the opioid epidemic. They play a key role in how the epidemic in 
America has been shaped since the government recognized the damage opioids can cause.  
Although the rate of opioid prescriptions drastically declined after the intervention, 
opioid drug overdose deaths continued to climb severely (Pryor, 2017). Opioid addicted persons 
who were once able to get their drug from a doctor found opioid prescriptions difficult to access 
at the rate necessary to keep up with their addiction. To avoid withdrawal sickness, they were 
forced to look for opioids elsewhere. Purchasing opioid prescription pills illegally can be 
expensive and is more difficult since the implementation of stricter prescribing policies. In this 
predicament, opioid abusers turned to something cheaper and more accessible – heroin and 
fentanyl. When patients' access to opioids is stopped abruptly without support and treatment, 
they are at high risk of replacing their supply with these illegal and dangerous street drugs 







Heroin and Fentanyl 
 Scholars claim it was around 2010 that many opioid addicted users moved on to 
intravenously injecting heroin. Heroin related overdose deaths peaked at this time. From 2002 to 
2013, deaths from heroin increased by 286% (Lui, Pei, & Soto, 2018). Although heroin has been 
on the market in the US for many years, the demand for the drug increased after the decline in 
opioid prescriptions. Drug markets throughout the United States began profiting from heroin 
sales, realizing how many people were already addicted to opioids and willing to be customers. 
However, the worse of the opioid epidemic did not come until the deadly combination of heroin 
and fentanyl became popular (Lui, Pei, & Soto, 2018). 
Fentanyl was first developed in 1960 as a powerful painkiller and surgery anesthetic 
without the side effect of nausea. It is prescribed in controlled settings for the most serious 
conditions, such as to treat cancer pain, and usually dispensed in patches or lollipops (Dibble & 
Davis, 2018). The drug is 25 to 50 times more potent than heroin (Lui, Pei, & Soto, 2018). Drug 
cartels quickly found a way to process the drug cut into heroin, creating a lethal mixture. Heroin 
began being cut with so much fentanyl that some people who were buying heroin were really 
buying pure fentanyl. The deaths caused by fentanyl laced heroin did not deter addicts from 
purchasing the drug. In fact, the increased high fentanyl gives draws them closer to it (Macy, 
2018). 
There has been a drastic increase in overdose deaths since the introduction of fentanyl in 
heroin. The potency of the drug is dangerous, and it has clearly contributed to a larger proportion 
of overdoses in the US. In 2015, it was involved in nearly 50% of opioid-related deaths, up from 
14% in 2010 (National Institute on Drug Abuse, 2019). The following year, synthetic opioids 
(primarily illegal fentanyl) passed prescription opioid pills as the most common drug involved in 
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overdose deaths in the United States. In 2017, fentanyl laced heroin became the leading cause of 
deaths for adults under the age of 50, killing more citizens than guns and car accidents, at a rate 
higher than the HIV epidemic at its peak (Katz, 2017). The implications of these statistics are 
grim and show the rapid increase and severity of overdoses since the introduction of fentanyl. 




  The events described in this paper are only a summary of the turmoil and loss that 
the opioid epidemic has caused this country. To comprehend the opioid epidemic in the United 
States it is essential to fully uncover the history of opioids. The incidents that led up to the opioid 
crisis are important to understand when attempting to create interventions to combat opioid drug 
overdoses. An issue that began as overprescribing opioid pills by doctors and physicians, quickly 
escalated to thousands of people addicted to synthetic opioids and heroin now turning to drug 
markets to feed their addiction. Many government officials, criminal justice officials, and 
citizens have placed blame for the crisis on pharmaceutical companies, like Purdue Pharma. It is 
their hope that with each intervention geared toward combating the opioid epidemic, we will 
begin to see a decrease in the drug overdose deaths in the US. The fight against the opioid 
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The United States government declared the opioid epidemic a public health emergency in 
2017. The same year, drug overdose deaths claimed over 72,000 American lives (Jones, 2018). 
The increase in opioid overdoses are a cause for concern for nearly everyone in the country. 
Having never experienced an epidemic so severe, government officials were forced to respond to 
the public outcry and devastation that opioids have triggered. Federal and state government’s 
responses range in tactics and strategies and may address different aspects of the epidemic. Some 
interventions that have been implemented to fight the opioid problem may be more criminal 
justice focused, while others may be geared towards a medical perspective. Analyzing the 
theoretical background of each intervention will bring a deeper understanding of how the nation 
is addressing the opioid epidemic. 
Although responses to the epidemic can vary in nature, government agencies and officials 
share similar goals – to stop the opioid epidemic. However, the strategies may serve to combat 
different aspects of the epidemic. The purpose of this paper is to highlight responses that federal, 
state, and local governments have used to tackle problems caused by the opioid crisis. To 
provide an overview of types of responses, I have chosen to analyze three criminal justice 
focused interventions and three medically focused interventions to compare their logic and 
effectiveness. I will discuss each response in detail and my reasoning behind the choosing of 
these six responses. Comparisons of the different responses used to fight opioids are extremely 
important due to the seriousness of the epidemic. It is imperative that medical, criminal justice, 
and public officials are implementing the best practices to ensure that these strategies are 




Criminal Justice versus Medical Responses 
To begin the discussion of the government’s responses to the opioid epidemic, explaining 
in detail the differences between criminal justice focused responses and medically focused 
responses is imperative to differentiate the theoretical backgrounds of each. Criminal justice 
responses typically involve actors from the criminal justice system (i.e. police, prosecutors, etc.)  
participating in the intervention. A response may also be considered criminal justice based if the 
person is receiving a punitive sanction due to their involvement with opioids. However, with the 
death toll from opioids continuing to climb every year, many criminal justice responses in the US 
are now prioritizing public health and including some medical qualities within the response. The 
criminal justice responses that will be examined in this paper are the prosecution of drug dealers 
in fatal overdoses, the implementation of drug treatment courts, and policing initiatives and 
interventions.  
I chose to discuss the prosecution of drug dealers in fatal overdoses because it is perhaps 
the most extreme criminal justice approach to combat the epidemic. This approach also directly 
targets drug dealers and does not offer any treatment for opioid addicted persons. Drug treatment 
courts were chosen for this paper because of their popularity. Drug courts have been used in the 
US criminal justice system since 1989 to combat drug addicts entering in and out of prison. 
However, this paper will analyze the effectiveness of drug treatment courts on opioid addicted 
persons, because there may be differences in treating opioid addicted persons compared to 
persons addicted to other illicit substances. Lastly, policing initiatives and interventions were 
chosen for this paper to show the change in policing, from tough to more liberal, toward the 
opioid epidemic. Literature shows that many policing initiatives now include treatment and 
medical tactics toward those addicted to opioids.  
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 A medical response to the opioid epidemic can be defined as completely focused on 
public health and may involve the use of medicines or other remedies to treat opioid addiction. 
Medical interventions do not seek to punish for opioid addiction, but rather assist opioid addicted 
persons rehabilitation and treatment (Phillips, Ford, & Bonnie, 2017). Their strategies are harm-
reducing and wish to prevent deaths, addiction, and diseases that occur as a result of the opioid 
crisis. The examples of medical responses that will be highlighted below are Medically Assisted 
Treatment (MAT), the use of Naloxone/Narcan, and the implementation of opioid prescribing 
policies.  
The medical responses discussed in this paper were also each chosen for specific reasons. 
MAT has been discussed in the literature to treat opioid use disorder by many different scholars 
and has often had positive results. The success of this intervention in reducing opioid overdoses 
is compelling and necessary to study. The use and distribution of Narcan in the United States is 
perhaps the most popular response to combating opioid overdoses, and its popularity gives it 
extreme importance to this paper. Finally, I chose to discuss opioid prescribing policies in this 
paper because that was also a popular response by the US government. The intervention may 
have also had unintended consequences that contributed to the epidemic, which makes 











Naloxone (Narcan) Policies 
 Naloxone was developed in the early 1960s as an opioid antagonist with fewer side 
effects than other drugs offered before its creation. Administration of the drug can temporarily 
reverse the potentially deadly effects of an opioid overdose. The distribution and use of Narcan is 
a harm-reducing medical strategy meant that targets opioids overdose deaths. Naloxone is 
approved for administration by a variety of routes, including intravenous (IV), intramuscular 
(IM), subcutaneous (SQ) and intranasal (IN), but is also administered via inhalation following 
nebulization or endotracheal tube in intubated patients (Lynn & Galinkin, 2018).  
Narcan is regulated by the FDA and in 2014 they approved the use of Narcan in an opioid 
emergency for the general public. Thirty-six states in the U.S. have approved the distribution of 
Narcan kits to members of the community without having a prescription (Pryor, 2017). It is now 
completely legal throughout the US. Opioid related overdose numbers have been so drastic, the 
government has been extremely lenient in their policies surrounding Narcan. Their hope is that 
by making access to Narcan easier, more people will have it available to use during an opioid 
overdose emergency, decreasing the number of fatal overdoses in the country. Products recently 
approved by the FDA for administration by non-medical bystanders include an intramuscular 
autoinjector, Evzio, approved in April 2014, and a spray device for intranasal delivery, approved 
in November 2015 (Lynn & Galinkin, 2018). Narcan is easy to use and there are in person and 
online trainings that are offered to any member of the public. 
As mentioned earlier, Narcan may be the most common intervention used across the US 
to combat the opioid crisis.  A study conducted by the Center for Disease Control and Prevention 
(CDC) found that from 2012 to 2016, an increase occurred in the number of EMS events with 
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naloxone administration. During these years, the rate of naloxone administration events overall 
increased 75.1%, from 573.6 to 1,004.4 administrations per 100,000 EMS events, and the rate of 
naloxone administration in suspected overdoses increased 119.0%, from 230.6 to 505.2 (Cash et 
al., 2018).  
 There have been studies conducted surrounding the impacts of Narcan distribution on 
opioid overdose mortality rates. A study done in Massachusetts evaluated the impact of state 
supported overdose education and nasal naloxone distribution (OEND) programs on rates of 
opioid related death from overdose and acute care utilization. The study used an interrupted time 
series analysis to measure the results. Researchers found a statistically significant reduction in 
opioid related death rates after the OEND program was implemented and Narcan began being 
used in communities (Walley et al., 2013). Another study conducted in 2011 found that overdose 
death rates fell from 46.6 per 100,000 to 29.0 per 100,000 in the year following the introduction 
of an overdose-prevention program that included the distribution of naloxone to community 
members (Albert et al., 2011).  
 The cost of Narcan kits can range depending on medical coverage of the individual or 
agency. They are typically sold in drug stores for approximately $130. However, EVZIO kits are 
sold at $178 per carton (two auto-injectors per carton, $89 per dose) for government agencies, 
first responders, health departments, and other qualifying groups. Narcan has a shelf life of 
approximately 18 to 24 months, so it can be saved for future use in case of an overdose 
emergency. Even after the drug expires, experts state it should still be used in case of a fatal 
overdose if there are no other options (Pirani, 2017). This is a limit to how much help Narcan can 
provide for combating the opioid crisis. Because the kits are expensive, they may be difficult for 
addicted persons to retrieve. Also, heavy users may need to have Narcan administered more than 
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once in their lifetime, therefore people will need more than one kit. The cost of Narcan is a 
critique of the policies regarding it, especially in the United States where citizens don’t have 
access to universal health care (Pirani, 2017). The availability of Narcan kits in case of an opioid 
overdose is an issue that public health agencies recognize and are attempting to solve.  
Another limitation encountered with Narcan is the lack of scientific information available 
on its side effects, especially among people who have drug administered repeatedly. As the 
number of naloxone products intended for use in such non-medical settings grows, so too does 
concern about appropriate dosing of this medication to ensure the reversal of life-threatening 
opioid overdoses while minimizing the risk of adverse effects of Narcan. There is also a concern 
about using Narcan on pregnant women and children because Narcan does not provide a label on 
how or if they should use the drug during an overdose situation.  
Although most government agencies claim there are no significant side effects of Narcan, 
some scholars argue that the dosage of Narcan given in an overdose situation matters. People 
suffering from opioid use disorder often experience opioid-induced respiratory depression. Some 
studies have claimed that high doses of Narcan can have potentially dangerous side effects on 
respiratory depression, causing the person to experience cardiac arrest (Lynn & Galinkin, 2018). 
Despite these challenges, in 2015 the American Association of Poison Control Centers reported 
no fatalities due to naloxone other than buprenorphine/naloxone combinations (Lynn & Galinkin, 
2018). The benefits of Narcan to the community are imperative and seem to outweigh these 
limitations. The overdose reversal the drug executes is viewed as lifesaving.  
Medically Assisted Treatment (MAT) 
Medically assisted treatment (MAT) is the use of medication, usually combined with 
behavioral therapy or counseling, to treat opioid use disorders. In 2016, the federal government 
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passed the Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for 
Patients and Communities (SUPPORT) Act. The Act made several amendments to the 
Controlled Substances Act, allowing practitioners greater flexibility in the provision of medically 
assisted treatment (SAMHSA, 2019). Implementing MAT on state and local levels has proven 
difficult due to the lack of physicians that are permitted to prescribe the medications needed for 
MAT. Also, because MAT uses prescription medications like methadone, suboxone, and 
naltrexone to treat opioid use disorder (OUD), the public has mixed feelings on supporting it.  
Irrespective of the public opinion on MAT, there is literature supporting its effectiveness 
in reducing harm associated with the opioid crisis. Due to the abundance of empirical studies that 
have found this medical intervention is successful, scholars claim MAT is the central component 
of evidence-based treatment for opioid use disorder, regardless of whether it is combined with 
behavioral therapy (Knudsen, 2015). A randomized clinical trial conducted between 2009 and 
2013 found that participants in the medication assisted treatment group were significantly more 
likely to continue engaging in treatment and had significantly reduced days of self-reported illicit 
opioid use per week (Donofrio et al., 2015). Other studies have found similar results, in addition 
to findings of reduced risks of infectious-disease transmission and of engagement in criminal 
activities (Volkow et al., 2014). 
The positive impacts of MAT have been recognized by different government agencies, 
resulting in the implementation of MAT in some jails and prisons to treat offenders suffering 
from OUD. This tactic is not extremely common, but there is some literature on it. A study 
conducted in Baltimore evaluated the long-term impacts that MAT had on offenders 12 months 
post-release. The study found that there was a statistically significant difference in the likelihood 
of relapsing among participants who received methadone treatment and patients who did not. It 
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also showed that prison-initiated methadone maintenance treatment was associated with greater 
duration of treatment in the community during the 12 months post prison release compared to 
counseling in prison with passive referral at release or counseling in prison with initiation of 
methadone treatment admission upon release (Kinlock, et al., 2009). This finding implies support 
to some researcher’s argument discussed above – that MAT is the central component of 
evidence-based treatment for OUD, with or without therapy.  
Despite empirical support of the effectiveness of MAT, the intervention has several 
limitations. In 2018, the Committee on Medication-Assisted Treatment for Opioid Use Disorder 
created an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine 
to conduct a study of the evidence base on MAT for OUD. Specifically, the committee was 
asked to identify barriers to the successful implementation of the intervention. The committee 
found there were barriers with education, training, government policy, and healthcare delivery – 
creating a lack of access to MAT and providers qualified to give it. They also found barriers with 
a lack of knowledge on the effectiveness of MAT and the range of parameters and circumstances 
in which it can be effectively delivered (i.e. duration of treatment, populations, settings, etc.) 
(National Academies of Sciences, Engineering, and Medicine, 2018). This implies the limitations 
of MAT are not insignificant and should be continued to be reviewed by scholars and public 
officials.  
Opioid Prescribing Policies 
The final medical response to examine, opioid prescribing policies, is an intervention 
where government officials implement policies that regulate pharmaceutical companies and 
physicians from continuing a pattern of overprescribing. Between 1999 and 2010, there was a 
300% increase in the prescription of opioids in the United States (Kahler et al., 2017). In 2016, 
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health care providers across the US wrote more than 214 million prescriptions for opioid pain 
medication—a rate of 66.5 prescriptions per 100 people. According to the Center for Disease and 
Control Prevention (CDC), the total economic burden of prescription opioid misuse in the US is 
$78.5 billion a year, including the costs of health care, lost productivity, addiction treatment, and 
criminal justice involvement (Center for Disease Control and Prevention, 2018).  
A study done between 2006 and 2015 measured the characteristics of a patients first 
opioid prescription and its long-term impacts. Using a random sample, medical records were 
selected from the IMS Lifelink+ database of patients 18 years or older who had at least one 
opioid prescription during June 2006 and September 2015, and 6 months or more of continuous 
enrollment without an opioid prescription before their first opioid prescription. The study found 
that the likelihood of long-term use increasing sharply after the third and fifth days of taking a 
prescription and spiking again after the 31st day (Shah, Hayes, & Martin, 2017). The following 
graph represents data on a 1-year probability and a 3-year probability percentage of continued 
use of opioids after the days first supply of opioid prescriptions;  
 
*Source: (Shah, Hayes, & Martin, 2017) 
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The chart shows the probability of opioid use continuing after the first use significantly 
increases. The information in the chart implies that it is easy to get addicted to opioids after your 
first use. It also provides a solid logic to the government’s decision to respond to the opioid 
epidemic with prescribing policies. By decreasing the number of people who ever take an opioid 
prescription, governments have restricted opioid prescribing and regulated those who currently 
possess an opioid prescription. Despite the solid logic behind these policies, scholars claim 
opioid prescribing policies only impact potential new opioid prescription users and do not help 
the population of people currently suffering from opioid addiction (Phillips, Ford, & Bonnie, 
2017).  
Opioid prescribing policies vary based on state. Each state has implemented their own 
laws and regulations surrounding the prescriptions of opioid pills. Although the policies differ 
from state to state, they are all primarily based around five main strategies. I have created the 
following table to illustrate the different types of prescribing policies and what they consist of 
(Shah, Hayes, & Martin, 2017); 
Types of Opioid Prescribing Policies 
1. Prescribing limits and 
guidelines 
Restrictions based on the quantity of pills and/or number of 
days prescribed. 
2. Mandatory prescription 
monitoring 
Regulations mandating the close monitoring of persons 
receiving opioid prescriptions.   
3. Standards of care Pushing medical practitioners to offer the best care and 
treatment to patients suffering from opioid use disorder. 
4. Prescriber education Regulations mandating the continued education of doctors, 
nurses, physicians, and any other medical workers who can 
prescribe opioids.   
5. Expanded access to treatment Overcoming barriers to securing insurance coverage to all 




These types of policies are based on three categories of prescribing policies; 1.) diversion before 
a prescription has been filled, 2.) diversion during the filling of a prescription, and 3.) diversion 
after a prescription has been filled (Phillips, Ford, & Bonnie 2017).   
States have adopted several policies that fall into one of these categories. As of 2017, 49 
states have adopted mandatory prescription drug monitoring programs (diversion after a 
prescription has been filled), 19 states set day prescribed limits for written opioid prescriptions 
(diversion during the filling of a prescription), 34 states mandate substance abuse disorder 
assessments prior to receiving any opioid prescription (diversion before a prescription has been 
filled), 23 states mandate continuing medical education for any providers who can prescribe 
opioids (diversion before a prescription has been filled), and 13 states have set limits on opioid 
prescribing diversion before a prescription has been filled (Pryor, 2017). These are only a few 
examples of the long list of new regulations on prescribing. 
 In May 2016, Massachusetts Governor Charlie Baker signed a comprehensive bill that 
addressed education, intervention, and prevention on opioid abuse. In this bill, a strict limitation 
law on opioid prescriptions was enacted and opioid prescriptions in the state took a downward 
turn with a 16% decline in number of patients receiving opioid prescriptions (Pryor, 2017). This 
would imply success of the intervention, but we must be skeptical of this knowing prescribing 
policies do not have an impact on high-risk populations currently already addicted to opioid 
substances. Mandatory prescription drug monitoring programs may be more useful in combating 
the epidemic because they screen patients for previous opioid prescription abuse before allowing 





Criminal Justice Responses 
Prosecuting Opioid Dealers for Homicide 
The United States federal law has included a penalty of 20 years to life in prison for 
providing drugs that cause fatal overdoses since Congress passed the Anti-Drug Abuse Act of 
1986 (Collins, 2019). Gaining more popularity among criminal justice officials in recent years, 
the prosecution of drug dealers for homicide in fatal opioid overdoses has been used as a 
response to the opioid epidemic by many state governments (Neil, 2019). A significant number 
of states count drug offenses within their murder statutes and, while the laws have been around 
for a long time, they are only now being considered in opioid overdose cases in response to the 
epidemic (Neil, 2019). There has been a push to be “tough on dealers” throughout the country 
and law makers and prosecutors have been directed to do so. Twenty states now have “drug-
induced homicide” laws that carry the same sentences as murder and manslaughter (Collins, 
2019). Thirty-six states have now successfully prosecuted opioid overdose cases, with charges 
ranging from involuntary manslaughter to first-degree murder (Goldensohn, 2018). 
Prosecuting opioid dealers in fatal overdose cases uses a general deterrence approach to 
combat the illegal sale of opioid substances. The deterrence theory argues that the more severe, 
certain, and swift a punishment, the more likely a rationally calculating human being will abstain 
from criminal acts. General deterrence suggests that the general population will be deterred from 
offending when they are aware of others being apprehended (Tomlinson, 2016). This criminal 
justice approach uses general deterrence by giving severe punishments to opioid dealers to deter 
other dealers from continuing to engage in their criminal behavior. Criminal justice officials 
hope that by increasing these convictions, opioid dealers will see how much prison time they can 
receive for what they are doing. These cases are often covered in the media to get the message 
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out to drug dealers. From 2011 to 2016, the number of news stories about people charged with or 
prosecuted for drug-induced homicides increased from 363 to 1,178 – more than a 300% 
increase (Collins, 2019).  
This strategy has many limitations. First, it is often difficult for prosecutors to reach 
convictions in these cases. According to the National Association of Attorneys General, when 
attempting to prosecute someone for a homicide, causation of death must be determined. With 
many outside circumstances existing, it becomes difficult for a prosecutor to prove causation of 
death was due to the illicit substance the person used (Neil, 2019). Also, despite its rising 
popularity in the legal system, studies suggest that this intervention is not effective, and there is 
little evidence that publicizing lengthy prison terms will make dealers think twice about 
continuing to sell opioids (Siegel & Beletsky, 2018).  
Along with these limitations, many law makers believe this tactic is unfair and has 
unintended consequences. Tough prosecution strategies may discourage people from calling 911 
to help overdose victims and may fuel higher arrest rates for people who are not dealing opioid 
substances. Instead of targeting drug dealers, charges are often being brought against family 
members or friends who shared illegal opioids with the deceased (Goldensohn, 2018). The 
unintended consequences mentioned are not insignificant and imply that this policy needs to be 
examined further to determine its impacts on the opioid epidemic.  
Drug Treatment Courts 
 Drug treatment courts can be defined as a program within the judicial system that deals 
with nonviolent criminal cases involving drug users (“A Comprehensive Guide to Drug Courts”, 
2017). Although specialty drug treatment courts are known to focus on rehabilitation of the 
offender, using drug courts as an intervention to combat opioids can be considered a criminal 
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justice response. State and local criminal justice agencies continue to use drug courts to fight 
against opioid addiction, despite conflicting literature on their effectiveness.  
 In a study done by the Urban Institute, a 6-year national evaluation of multi-site adult 
drug courts was conducted to evaluate their effectiveness. The study included 23 adult drug 
courts all located in different geographic locations throughout the US. Though the study was not 
a randomized control trial, researchers performed a quasi-experimental method using self-report 
survey data, field visits, administrative records, and oral fluid tests. Researchers conducted a 6-
month and 18-month follow-up with participants to achieve accurate results (Rempel, 2012). 
 The study found that at the 6-month follow-up, 40% of drug court participants compared 
with 55% of comparison offenders self-reported that they had used at least one of eight measured 
substances. This was a significant difference. However, there was no significant difference in the 
percentage of drug court and comparison offenders self-reporting serious drug use (32% versus 
40%). By the 18-month follow-up, drug court participants reported significantly fewer 
occurrences of any drug use (56% versus 76%), serious drug use (41% versus 58%), days of use 
per month (2.1 days versus 4.8 days) and days of serious use per month (1.1 days versus 2.3 
days). Also at the 18-month follow-up, the oral swab tests administered determined that drug 
court participants had a significantly lower rate of testing positive than the comparison offenders 
(29% versus 46%). Unfortunately, when examining specific drugs that were tested, there were no 
significant differences between the groups in the rates of positive drug tests for marijuana, 
cocaine, opiates, or amphetamines (Rempel, 2012). 
 There are some implications from the findings of this study that must be considered when 
evaluating the impact of drug courts on the opioid epidemic. Based on these results, it appears 
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that drug courts are effective in reducing the likelihood of using drugs after completing the drug 
court. However, after time there were no significant differences among drug use for opiates. 
Opioid addiction and withdrawal may be described by some as more severe than that of other 
drugs and the number of overdoses from opioids is higher than any other drug the country has 
seen. The results of the study imply that changes in drug treatment courts may be necessary to 
increase their effectiveness in combating the opioid epidemic.  
To more effectively combat the epidemic, these changes in drug courts are already 
beginning to be made in drug courts throughout the country. For example, in 2017, a new 
specialty drug treatment court was introduced in Buffalo, NY that is tailored specifically to 
offenders suffering from OUD. The Buffalo Opioid Intervention Court, run by Judge Craig 
Hannah, uses different tactics including MAT and behavior counseling to offer the best treatment 
possible. The court has received positive feedback from the community and its model is already 
being replicated in other courts (Viera, 2019).  
Policing Interventions and Initiatives 
  To combat the opioid epidemic, many law enforcement agencies in the US have 
implemented different policing initiatives to attempt to decrease opioid related overdoses. Some 
commonly used interventions by police agencies to fight the opioid crisis include problem-
oriented policing (POP), community-based policing, and police assisted recovery initiatives. 
These policing initiatives have similar qualities, but each initiative uses different strategies in 
tackling the epidemic.  
Community-based policing involves a strong partnership between local law enforcement 
and the community they serve. Community policing initiatives operate on the belief that a better 
relationship with the community will decrease crime problems in that neighborhood. 
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Community-based policing initiatives may involve police walking on foot in neighborhoods, 
getting to know the residents, treating residents with respect and kindness, making their presence 
known in any local stores or businesses, and being present in any community building tasks the 
neighborhoods may be participating in. By being more thoughtful and innovative in dealing with 
neighborhood issues, police can gain trust and be more effective in their policing (Clear, 
Hamilton, & Cadora, 2011). Because many communities have been directly impacted by the 
opioid epidemic, many community-based policing initiatives are being created to work with 
residents on combating these issues.  
There have been positive findings regarding the implementation of community policing 
initiatives. A community policing pilot project that started in 1993 in Chicago was evaluated 
after two years. The findings were very encouraging. It was found that perceived crime problems 
had decreased significantly, robbery and auto theft declined, residents had more positive attitudes 
towards the police and police supervisors involved in the study were more optimistic than their 
counterparts about the impact of community policing (US National Institute of Justice, 1995). 
Problem-oriented policing initiatives collaborate with government and non-profit 
agencies to fight opioid riddled neighborhoods (Corsaro & McGarrell, 2014). Problem-oriented 
policing targets illegal drug markets and problem offenders. There are several tactics POP 
utilizes to uncover illegal opioid drug markets. First, officers may use field investigations and 
data analysis to discover hot-spot area and problem offenders. Once target areas and high-risk 
offenders are identified, law enforcement can use focused deterrence to combat the drug market 
(Altheimer et al., 2019). Problem oriented policing also uses opportunity reduction in the 
physical environment to disturb operating drug markets. The goal of POP is not to just arrest 
offenders, but to disrupt the mechanisms of the market’s survival (Harocopos & Hough, 2005).  
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Studies exist that have examined the effectiveness of POP initiatives and found positive 
results. In High Point, NC, researchers conducted a study on a POP initiative called the High 
Point Drug Market Intervention. The neighborhood the intervention targeted had crime problems 
directly associated with a known drug market operating in the community. Researchers found 
that the intervention had a statistically significant impact on reducing violent incidents in the 
target areas. Targeted census blocks (treatment group) experienced a 7.9 percent decrease in 
violence, while the comparison blocks experienced a 7.8 percent increase in violence 
(McGarrell, 2014).  
 Another policing initiative that is geared toward helping persons suffering from OUD is 
police assisted recovery initiatives. This intervention has been implemented to provide other 
options for opioid addicted offenders besides arrest. The purpose of these programs is to reduce 
unnecessary justice system involvement and instead give them assistance finding treatment 
(Nyrop, 2019). Police diversion interventions allow officers to use their discretion when 
encountering persons with unmet opioid abuse needs. They can then use outreach strategies to 
assist the person in connecting with an appropriate treatment agency (Nyrop, 2019). The opioid 
epidemic prompted the onset of these new recovery-based police initiatives due to the public 
harm it has created. Although literature on this initiative is sparse due to its recent invention, law 
enforcement agencies are confident in its harm-reducing tactics to deal with the epidemic.  
 
Funding of Reponses 
 Now that several responses to the opioid epidemic have been identified, it is helpful to 
analyze government funding for these interventions to understand how the US has spent taxpayer 
money on these responses. A large amount of money has been spent on interventions to stop the 
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opioid epidemic. To analyze the distribution of this money, the Bipartisan Policy Center has 
broken down funding by department and type of response. I will examine government funding 
on the opioid epidemic for the most recent year, 2018. The following chart lists the different 
government departments that were awarded funding from the federal government for the opioid 
crisis in 2018; 
Department  Amount 
Health and Human Services $5,521,368,000  
     Substance Abuse and Mental Health  
     Services Administration  $3,685,479,000  
    Indian Health Service $6,000,000  
    Centers for Disease Control and Prevention $630,579,000  
    Health Resources and Services Administration  $480,000,000  
    Administration for children and families  $125,310,000  
   National Institutes of Health $500,000,000  
   Food and Drug Administration $94,000,000  
Office of National Drug Control Policy $379,000,000  
Department of Justice $515,839,484  
Veterans Affairs $704,552,000  
Homeland Security $261,100,000  
Department of Labor $21,000,000  
Total Opioid Spending 2018 $7,402,859,484  
*Source (The Bipartisan Policy Center) 
 
These agencies all serve to address the opioid epidemic differently. For example, Health and 
Human Services may be distributing their funds to programs that are more medically focused, 
while the Department of Justice may utilize their funds on a criminal justice focused 
intervention. I created the following two charts to illustrate how these funds were spent in 2018, 














*Source (The Bipartisan Policy Center) 
 The charts show that the most funding the United States government distributes is for 
programs involving treatment, prevention, or both. Despite the growing number of criminal 
justice-based responses, they are not funded as much as expected by the federal government. 
However, it is necessary to keep in mind that programs like drug treatment court and police-
based initiatives that focus on treatment, may be included under the “treatment and recovery” 

















Type of Response Amount 
Treatment and Recovery $2,115,574,000  
Prevention $1,684,442,800  
Treatment/Recovery & Prevention $1,903,103,200  
Research $500,000,000  
Criminal Justice $532,639,484  
Law Enforcement $312,000,000  
Interdiction $355,100,000  
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recognition of opioid use disorder as a disease that requires appropriate care. The high spending 
on prevention implies the government’s recognition of the severity of opioid-related overdoses. 
 
Implications 
The long and varying list of responses that the US government has implemented to deal 
with the opioid epidemic show the disorganization and uncertainty of the law makers 
surrounding the topic. The opioid epidemic is a massive problem spread across the entire nation, 
and the implications of this paper show that government officials are unsure what is the best way 
to stop opioid overdose deaths. There is a lack of knowledge and understanding around what 
interventions are successful in combating the opioid crisis. This lack of understanding suggests 
that the opioid epidemic may be progressing because our government has not implemented 
responses that are proven to work. 
Scholars have critiqued government interventions by stating that the unique dynamics of 
opioid misuse – both in the medical industry and in the illegal markets – requires a ‘systems’ 
approach that integrates multiple government sectors (i.e. criminal justice & medical) to address 
the epidemic (Phillips, Ford, & Bonnie, 2017). This systems approach may stop the divide that 
we see in government interventions currently. As described in some of the responses above, 
government agencies are beginning to collaborate more often when implementing interventions 
to stop the opioid emergency. For example, drug treatment courts beginning to address offenders 
with OUD and offer them treatment options such as MAT. This collaboration between treatment 
officials, medical officials, and criminal justice officials may be key in finding interventions that 
are completely effective in reducing opioid overdoses. The research in this paper implies that a 
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mix between the criminal justice and medical field is necessary when making interventions to 
combat the opioid crisis.   
 
Conclusion 
 The purpose of this paper was to describe how federal, state, and local governments have 
reacted to the devastation that opioids have cause the country. The interventions that were 
discussed range from being either medically focused or criminal justice focused. Each response 
examined is unique and was implemented to put a dent in opioid overdoses. There are multiple 
criminal justice approaches and medical approaches that are being used simultaneously to fight 
the opioid epidemic. Knowing which interventions are more successful and reduce the most 
harm is critical. More empirical evaluations on these interventions are necessary to determine the 
effectiveness of each. While there are mixed views on which is approach most beneficial to 
combat opioids, both types of interventions are constantly being created and implemented across 
the country without scientific certainty of success. The importance of this issue should be 
emphasized because the country is still experiencing the negative impacts from the opioid 
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The opioid epidemic was responsible for over 72,000 opioid drug overdose deaths in 
2017 (Jones, 2018). Because of the severity of the epidemic, policy makers have been forced to 
enact strategic legal policies, practices, and laws, to attempt to combat the opioid crisis. The 
criminal justice system and the public health system have worked together in ways to create 
policies that will curb the high number of opioid deaths. By addressing the epidemic from both 
criminal justice perspectives and medical perspectives, there may be conflicting opinions and 
which tactic will best solve the crisis. However, criminal justice sectors and public health sectors 
in Monroe County have both participated in creating interventions that aim to address the 
epidemic.  
To analyze what is being done in Monroe County, NY surrounding the opioid epidemic I 
will focus on different interventions that have been implemented in recent years. Public officials 
and agencies in the county are currently addressing the opioid epidemic with different strategies 
that aim to decrease problems directly caused by opioids. The purpose of this paper is to provide 
an overview of these interventions and discuss the strategies the intervention uses to help combat 
opioid overdoses in Monroe County. Though Monroe County has implemented several 
interventions to fight opioids, I will focus on three responses in this paper. The three responses 
are the Monroe County Heroin Task Force, Project CLEAN, and the implementation of 
Medically Assisted Treatment (MAT) at the Monroe County Jail (MCJ). Each response has 
different qualities, and one may have more impacts than the others. Thus, it is important to study 
the responses offered in Monroe County to attempt to determine the best practices in battling the 




Importance of Opioids in Monroe County 
 The opioid epidemic has drastically impacted different states and counties throughout the 
US. For the purpose of this paper, it is important to show the severity of the opioid crisis in New 
York State and specifically, Monroe County. In New York State, there was a 71% increase in 
drug overdose deaths from 2010 to 2015. Using provisional NYS Department of Health Data, a 
study conducted found a 54% increase in heroin deaths, a 50% increase in emergency room visits 
due to heroin overdoses, and a 45% increase in the use of life-saving overdose medication, like 
Naloxone, in one year alone (2014-2015). From 2015 to 2016, drug deaths increased 29 percent 
— from 3,009 total deaths to 3,894 (Malatras, 2018). 
 Monroe County, NY has experienced similarly shocking statistics. The following chart 
shows opioid overdoses in Monroe County over the last three years; 
Table 1 
 
*Graph created by Abigail Hallowell, Research Assistant with the Center for Public Safety Initiatives  
In 2016, there were 82 fatal overdoses and 260 non-fatal overdoses. In 2017, the number 
























2018, there was a slight increase for fatal overdoses from the previous year (n=145). The same 
year, a similar pattern is reflected with non-fatal overdoses drastically increasing (n=967). The 
high number of fatal and non-fatal overdoses shown in the graph reflect the prominence of 
opioid abuse in Monroe County.  
Monroe County also faces challenges in certain communities with illegal opioid drug 
markets. A medium-sized city located in the center of the county, Rochester, NY is home to the 
majority of all the overdoses in Monroe County. The following chart illustrates opioid overdoses 






























As illustrated in the chart, over half of the overdoses that occurred during this timeframe 
took place in the city of Rochester (n=1,590).  Because many of these overdoses are from people 
who do not reside in the city, it is assumed that they are coming in to the city to purchase illegal 
opioid substances, ingesting them immediately, and thus overdosing within the city confines. 
The operation of illegal opioid drug markets and the increasing number of overdoses in Monroe 
County are a cause for concern. These issues have forced Monroe County officials to implement 
several interventions discussed in detail below.  
 
The Monroe County Heroin Task Force 
The Monroe County Heroin Task Force, implemented in January 2018, is a collaboration 
between the Monroe County Sheriff’s office, the Monroe County District Attorney’s office, the 
Monroe County Public Safety Office, the Monroe County Public Health Commissioner, the 
Rochester Police Department, Ogden Police Department, and the Gates Police Department. 
These groups have partnered together to address the heroin crisis in Monroe County. I chose to 
discuss this response because it is the largest and most prominent intervention that has been 
implemented to combat the opioid epidemic in Monroe County. The intervention also has the 
largest range of tactics used to combat the epidemic. They have implemented several strategies 
that differ in nature but are each working toward the same goal – to decrease opioid related 
overdoses.  
Prosecuting Drug Dealers 
The first strategy that the Monroe County Heroin Task Force has taken in fighting the 
epidemic is attempting to prosecute persons who are responsible for the sale of illegal opioids 
that cause fatal overdoses. This criminal justice aspect of addressing the problem focuses on 
punishment and general deterrence to future dealers. The Heroin Task Force’s hope is that using 
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this response will lessen the number of illicit opioid dealers and suppliers on the street. This 
approach to stop the opioid epidemic is controversial across the country and it can be difficult to 
reach convictions for these occurrences. Nonetheless, the Monroe County prosecutor Sandra 
Doorely convicted a Rochester resident of criminally negligent homicide in 2018 when he sold a 
man heroin that lead to a fatal overdose (Singer, 2018).  
Because this strategy operates on a general deterrence theory approach, county officials 
have made sure to publicize these convictions through the media and other outlets. After the 
conviction, the police chief of a Monroe County town was quoted saying “If you're a drug dealer, 
you're playing Russian Roulette. We will come after you, and I think this case shows that we are 
serious about that." There have also been billboards put up throughout the county warning drug 
dealers of this new tactic (Flasch, 2018). This strategy assumes that drug dealers are rational and 
if they see other dealers receiving harsh sentences, they will be deterred from engaging in further 
criminal activity. Unfortunately, studies suggest that this intervention is not effective, and there 
is little evidence that publicizing lengthy prison terms will make dealers think twice about 
continuing to sell opioids (Siegel & Beletsky, 2018). 
Addressing Pharmaceutical Companies 
Another strategy that the Monroe County Heroin Task Force has listed as an intervention 
to combat the opioid epidemic is bringing charges against several pharmaceutical companies 
responsible for overprescribing opioids. The Heroin Task Force has pursued charges against 
large pharmaceutical companies such as Purdue Pharmaceuticals and Johnson & Johnson. These 
companies may be responsible for a large portion of the Monroe County population – and US 
population – that is addicted to opioids. 
45 
 
In April 2019, federal authorities pressed charges against a pharmaceutical company 
called the Rochester Drug Co-operative (RDC) that operates in Monroe County. The company is 
one of the 10 largest pharmaceutical distributors in the US, recently earning an annual profit of 
$2 billion. The RDC is responsible for driving up the sales of oxycodone pills drastically over 
four years, from 4.7 million in 2012 to 42.2 million in 2016 (Rashbaum, 2019). Prosecutors 
charged RDC as a corporate entity with conspiring to distribute drugs, conspiracy to defraud the 
United States and failing to file suspicious order reports. This response to the Rochester 
company is also publicized in the media and is used as a general deterrent strategy targeting 
other large pharma companies. Pursuing pharmaceutical companies for their crimes may 
decrease the number of opioids being prescribed, but it does not necessarily help opioid addicted 
persons who are currently at-risk of overdosing. 
  Recovery and Treatment Focused Strategies  
The Heroin Task Force uses other strategies to address the opioid crisis that may seem to 
contradict the deterrence method that they use to address drug dealers and pharmaceutical 
companies. The task force reinforces that they value treatment for addiction to prevent 
overdoses. The Monroe County Heroin Task Force website highlights that they partner with 
multiple non-profit agencies that provide outreach, counseling, and other resources committed to 
combating addiction. Each of these organizations address different aspects of the opioid 
epidemic within the community. For example, ROCovery Fitness and the Mission Recovery and 
Hope, Inc. are two non-profit organizations that partner with the Task Force. Both organizations 
base their program on abstinence and recovery from opioids. These interventions used by the 
Task Force imply that they are also interested in taking a rehabilitative and treatment focused 
approach in addressing the opioid epidemic.  
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The Monroe County Chief Executive Cheryl Dinolfo, a member of the Heroin Task 
Force, created an Opioid Action Plan to fight the opioid epidemic. The Action Plan provides a 
list of treatment focused interventions that will be used in Monroe County to combat opioids 
such as participating in community outreach, hiring more toxicologists, and collaborating with 
public health agencies. It is worth noting that the Heroin Task Force and the Opioid Action Plan 
in Monroe County utilize criminal justice, medical, and treatment focused responses to deal with 
opioid overdoses.   
Overdose Data Collection 
Another tactic of the Opioid Action Plan is to coordinate overdose data in the county. An 
issue encountered when attempting to study opioid overdoses in Monroe County is the lack of 
accurately recorded data. The Task Force’s goal of coordinating data is to streamline and 
centralize overdose data and overcome certain legal barriers that prevent them from retrieving 
the data. It is important to remember that there are limitations to the data presented by these 
agencies. Law enforcement, EMS workers, and the public safety community are responsible for 
collecting accurate and detailed information when someone overdoses. The data is susceptible to 
human error. Also, only recently did the precise collection of overdose data become a priority, 
due to the recent realization of the severity of the opioid epidemic by the public and government 
officials. Thus, overdoses that occurred before 2018 may have been recorded inaccurately or not 
recorded at all.  
To give an example of the county’s overdose data collection errors prior to 2018, there 
are differences in the number of fatal and non-fatal overdoses recorded within different 
government agencies for 2016 and 2017. The Monroe County Heroin Task Force and the Opioid 
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Action Plan contain different data on their websites for number of overdoses and overdose 
deaths. These discrepancies are illustrated in the following chart; 
 
*Source (Monroe County Heroin Task Force, 2018) & (Monroe County Opioid Action Plan, 2018) 
 
The Heroin Task force has recorded 766 overdoses and 220 fatal overdoses in 2017. This 
data was retrieved from the Monroe County Medical Examiner’s Office. In comparison, the 
Monroe County Opioid Overdose Data provided by the New York State Department of Health 
Quarterly Opioid County Report reported only 126 fatal overdoses in Monroe County for 2017. 
This disconnection in data within different sectors of the Monroe County government can be a 
huge hurdle when addressing the issue of opioids.  
The chart implies that there may be difficulty finding a standard and accurate way to 
record data on opioid overdoses in Monroe County. It may also imply that the importance of 
coordinating this data was not yet recognized by government agencies in the county. As stated 
earlier, now that the epidemic has severely impacted Monroe County, the Task Force has 
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Plan and tracking this data, officials in Monroe County may achieve a more precise 
understanding of the opioid epidemic and be able to shape policies based on the data. 
Narcan Use and Distribution 
 The final tactic implemented by the Monroe County Task Force to discuss in the 
increased use and distribution of Narcan during an opioid overdose. When the Task Force was 
created, it claimed that expanding training, education, and access to Narcan was a primary goal 
of the intervention. As of October 2018, all officers in the Rochester Police Department are now 
mandated to be trained on and always carry a Narcan kit. The use of Narcan in Monroe County 
has become extremely popular during the event of an opioid overdose. The following graph 
shows the administration of Narcan during opioid overdoses in Monroe County from January 
2016 to April 2019; 
 
The chart shows that over a three-year period of opioid overdoses in Monroe County, 
Narcan was administered in 72% of the time. This implies that the Task Force has been 
successful in the implementation of expanding the use of Narcan in Monroe County.  
72%
28%
ADMINISTRATION OF NARCAN DURING AN OPIOID 
OVERDOSE IN MONROE COUNTY JAN 2016-APRIL 2019




 Project CLEAN is an intervention in Monroe County to combat the opioid epidemic 
locally. It is part of a 3-year grant from the Department of Justice that is aimed at changing 
communities facing specific crime problems. The project started in 2016 and the entire first year 
was dedicated to planning. The second year of Project CLEAN began its Early Action Plan and 
the third year was the implementation phase of the intervention (Dude-Banwar, 2018). I chose to 
discuss Project CLEAN in this paper because its main purpose is to target the open-air drug 
market currently operating in the city of Rochester. The program uses several unique strategies 
that are important when discussing the opioid epidemic in Monroe County.  
The project is a Community Based Crime Reduction (CBCR) model that utilizes a 
collaborative approach with multiple organizations to disrupt the open-air drug market in the El 
Camino neighborhood in Rochester. This neighborhood has been deemed the target area for 
Project CLEAN due to the overwhelmingly high number of opioid overdoses and non-marijuana 
drug arrests that have occurred there. The heat map below depicts drug arrests in the city of 




. In 2017, there were 85 fatal overdoses in the El Camino neighborhood, a 
disproportionately large number for the general Monroe County area (Duda-Banwar, 2018). This 
small neighborhood has faced unique issues associated with the opioid epidemic. Project 
CLEAN uses a Problem-Oriented Policing (POP) community-based approach to clean up the El 
Camino neighborhood and reduce the negative impacts that the heroin market has on the 
community wellbeing and residents (Duda-Banwar, 2018).  
Project CLEAN created five strategy principals to guide the project, and each 
intervention the project uses should generally fit into one of the strategies. I have created this 
chart to list and discuss the five strategy principals; 
Project CLEAN Five Strategy Principals 
1. Strengthen/Support 
Neighborhood Engagement 
(Collective Efficacy)  
 
-Create prosocial activities at hotspot locations. 
2. Enhance Neighborhood and 
System Accountability (Procedural 
Justice) 
 
-Interview residents to determine their needs. 
3. Observe, Understand, and 
Respond (Public Health and 
Enforcement Surveillance)  
 
-Reoccurring walking community engagement patrols with 
two police officers.  
-Utilize calls for service data and arrest data to discover 
trends. 
 
4. Improve the Built-Environment 
(Revitalization)  
 
-Clean up target area (i.e. drug paraphernalia, garbage). 
-Reconstruct parks, abandoned buildings, and empty lots. 
-Sobriety or inspection checkpoints on key routes to the TA. 
 
5. Communicate and Connect 
 
-Coordinate social and visual campaign 




These strategy principals assisted in determining the project’s Early Action Plan that was 
implemented in the second year. The Early Action Plan consisted of 9 different strategies that 
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were implemented to combat the open-air drug market in the El Camino neighborhood. The 
different tactics listed in the plan are; 
1. Community Engagement Patrols: Law enforcement will engage with the community on 
walking patrols and build relationships and conduct business checks and physical 
disorder assessments. 
2. Disorder Policing and Targeted Patrols in the Target Area: Focused deterrence strategy 
also known as “hot-spot” policing, to deter dealers from selling opioids in public areas. 
3. Inspection or Sobriety Checkpoints on Key Routes to the Target Area: Officers will begin 
conducting frequent inspection and sobriety checkpoints near highways around the TA. 
4. Establish CPTED Assessment Process: Follow plans to combat the drug market by 
changing the surrounding environment to lessen the opportunity for drug sales and other 
illegal behavior  
5. Change Traffic Patterns: Modify infrastructure in TA to lessen the opportunity for so 
much incoming and outgoing traffic.  
6. Target Area Revitalization: Update public parks and empty lots, fix dilapidated buildings, 
clean up needles, etc. 
7. Create Prosocial Activities at Hotspot Locations: Engage the community in positive 
activities in the TA to deter drug sales in the area and gain public support 
8. Coordinated Social and Visual Campaign: ¡No Más! Campaign: Gain more public 
support of changing the open-air drug market culture by renaming parks, engaging in 
social media, etc. 
9. Create Service Connections via Direct Street Outreach in the Target Area: Offer 
treatment or other medical options for opioid addicted persons in the TA 
 
These tactics are specific to the El Camino neighborhood, and the open-air opioid drug 
market that operates within it (Duda-Banwar, 2018). Some examples of tactics Project CLEAN 
has executed following the Early Action Plan are; community needle clean ups, Rochester Police 
Department Community Engagement Patrols, revitalization of Don Samuel Torres Park, and 
conduct interviews with residents of the neighborhood. 
Literature on Similar Interventions  
There are numerous studies that have been conducted on community-based crime 
reduction interventions. When reviewing the current literature on this topic, studies that focus on 
programs that are comparable to Project CLEAN are sparse, likely because the program is so 
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uniquely tailored to the El Camino neighborhood in Rochester. However, the implications of 
some previous studies may help us formulate predictions on the effectiveness of Project CLEAN. 
One study worth discussing analyzes the effectiveness of a Community Based Crime 
Prevention Reduction program, Eisenhower Foundation's Neighborhood Program, in ten 
communities that face unique crime problems, like the El Camino neighborhood in Rochester. 
The authors highlight two issues with using a CBCR program in these communities. First, 
residents of high-crime communities are less likely than residents of low-crime communities to 
participate in community crime prevention programs. Second, typical community crime 
prevention strategies (i.e. neighborhood watch programs) seem to be typically less effective in 
such communities (Bennett and Lavrakas, 1989).   
The study includes both a process and impact evaluation of the Eisenhower Foundation's 
Neighborhood Program. For the process evaluation, the primary source of data was retrieved 
from in-person interviews with staff members, police officers, volunteers, local merchants, 
council members, and community residents. These interviews along with frequent visits to the 
sites, quarterly reports from the sites, and reviewing other files. For the impact evaluation of the 
program, a quasi-experimental pretest-posttest with a nonequivalent control group was used. The 
researchers assessed the programs impact on resident’s community activities, crime prevention 
activities and attitudes, perceptions of local problems, fear of crime, victimization experiences, 
and the community’s quality of life.  After determining problems areas, researchers conducted 
500 telephone interviews with residents (65% of respondents lived within the target areas) and 
analyzed monthly crime statistics from 1981 through 1985 (Bennett and Lavrakas, 1989). 
Despite successful implementation of the program, the general findings in the study show 
a lack of success in achieving the ultimate goals of crime reduction and improving neighborhood 
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quality of life. The level and consistency of positive community changes that can be documented 
were lower than anticipated. However, they stated that these findings may be a result of 
limitations to their study such as lack of funding for the program, the communities limited 
resource base, the magnitude of problems in these high-crime areas, and difficulties in 
documenting change produced by a community program and limitations to the evaluation 
(Bennett and Lavrakas, 1989). 
The findings appear grim for CBCR programs. The limitations with the program that the 
authors describe are ones that any CBCR intervention may face when trying to help communities 
with these unique crime issues. Based on the implications of the findings, Project CLEAN may 
face similar failures as the Eisenhower Foundation's Neighborhood Program. However, the 
authors mention that a successful CBCR intervention should be tailored to the needs of that 
community. As discussed earlier, Project CLEAN has successfully personalized its interventions 
to meet the specific needs of the El Camino neighborhood and its residents.  
Another study important to analyze when predicting outcomes for Project CLEAN was 
published in the Campbell Collaboration in 2012. The experiment analyzed 10 randomized 
control trials on hot-spot and problem-oriented policing interventions. The study found a 
significant small overall mean effect (n=0.116) in favor of hot spots policing. This implies hot 
spots policing strategies have a modest effect on reducing crime. However, it also found that 
problem-oriented policing approaches produced a larger overall mean effect size (n=0.232) that 
was twice that of the overall mean effect size for traditional policing approaches (Braga, 2012). 
The results imply that when combining hot-spot policing with problem-oriented policing, like 
Project CLEAN does, larger crime reductions effects are more likely. Unlike the previous study, 
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the findings in this study suggest that Project CLEAN may be effective in combating the opioid 
epidemic in Monroe County.  
 
Medically Assisted Treatment at the Monroe County Jail 
 In January 2019, the University of Baltimore issued Monroe County a $250,000 grant to 
bring Medically Assisted Treatment (MAT) into the Monroe County Jail (MCJ). The new 
program will combine behavioral and drug therapies (i.e. methadone, suboxone, and 
buprenorphine) to help inmates through opioid withdrawal. When inmates receiving MAT are 
released, they will continue their treatment in an outpatient facility. This response to the 
epidemic in Monroe County is medically focused, even though the program’s location is in a jail. 
The Monroe County Sheriffs office is the only law enforcement agency in the country to receive 
this funding (Thompson, 2019). This is an interesting point and may suggest that criminal justice 
agencies do not usually receive government funding for medically focused interventions. This is 
also the reason I chose to analyze MAT at MCJ in this paper.  
There is a wide range of literature supporting MAT’s effectiveness in reducing harm 
associated with the opioid crisis. Due to the abundance of empirical studies that have found this 
medical intervention is successful, scholars claim MAT is the central component of evidence-
based treatment for opioid use disorder, regardless of whether it is combined with behavioral 
therapy (Knudsen, 2015). A randomized clinical trial conducted between 2009 and 2013 found 
that participants in the medication assisted treatment group were significantly more likely to 
continue engaging in treatment and had significantly reduced days of self-reported illicit opioid 
use per week (Donofrio et al., 2015). Other studies have found similar results, in addition to 
findings of reduced risks of infectious-disease transmission and of engagement in criminal 
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activities (Volkow et al., 2014). The findings of these studies imply that MAT is effective in 
combating the epidemic and explain why Monroe County wanted the intervention implemented 
in the local jail.  
 
Conclusion 
 As United States communities and citizens continue to fight against the opioid epidemic, 
different interventions have been created to decrease overdoses and disrupt drug markets. The 
purpose of this paper was to highlight the multiple interventions in Monroe County that have 
responded to the opioid crisis. While the interventions have the same general goal, dissimilar 
strategies are used with each intervention. Some tactics may be more medically focused, while 
others are focused more punitively and are handled with criminal justice sectors. It is important 
to discover which type of intervention is the best practice for tackling the opioid crisis. With data 
on opioid overdoses only beginning to be accurately tracked and recorded recently, it is difficult 
to evaluate the effectiveness of each of these programs. By reviewing the literature on each 
intervention and conducting empirical evaluations on these programs, greater knowledge will be 
available on which practices are most successful in stopping the opioid epidemic in the country.  
 Although the data in this paper continues to reflect high numbers of fatal and non-fatal 
overdoses within Monroe County, there is hope within the grim statistics. Across the US and 
locally in Monroe County, there are constantly new interventions being implemented to combat 
the epidemic. Continuing to study and research the different methods used in each intervention 










“Analysis of Opioid Overdoses in Monroe County” 
























The opioid epidemic in the United States has negatively impacted the lives of thousands 
of people. The federal government declared the opioid problem a public health crisis in 2017, 
ending the year with over 40,000 fatal drug overdoses involving any opioid. Due to the severity 
of the crisis, government officials have responded by beginning to collect opioid overdose data 
and implementing interventions to combat overdoses. To evaluate the effectiveness of the 
responses in reducing opioid overdoses, it is essential that we gain an empirical understanding of 
what different factors influence if an overdose ends in a fatality.    
The purpose of this paper is to analyze opioid overdose data in Monroe County, NY. Using a 
secondary data analysis of this data we can attempt to analyze if there are any factors impacting 
fatal overdoses in the area. The research questions this study will address are;  
1. What factors impact if an opioid overdose will be fatal?  
2. Does the administration of Narcan during an overdose decrease the likelihood that an 
overdose will be fatal?  
3. Does having a prior overdose history increase the likelihood that an overdose will be 
fatal?  
Finding answers to these questions may help to inform local policy makers on the best practices 
to combat the opioid crisis. There are limitations to what we can conclude from this study that 
will be discussed later in the paper. Nonetheless, it is important to conduct this analysis to 








Importance of the Epidemic 
 A crisis unique to the United States, the opioid problem has become a significant and 
frightening topic in the country. Opioid related overdoses have been increasing since the mid-
1990s and the increases have become more severe in recent years. In 1999, drug overdoses 
claimed 16,849 American lives. In 2007, overdoses were responsible for 36,010 deaths. In 2017, 
fatal drug overdoses in the United States claimed 70,237 lives. Out of those fatal overdoses, 
about 68% involved an opioid. This is an enormous increase since 1999, and the number of 
overdoses has almost doubled since 2007 (National Institute on Drug Abuse, 2019). The 
significant increase in overdoses shown over the last two decades highlights the importance of 
the opioid epidemic in this country. Table one below displays the increase in fatal opioid 
overdoses in three separate waves since 1999; 
Table 2. 
 




























Three Waves Opioid Overdoses in the US 1999-2017
Commonly Prescribed Opioids Heroin Other Synthetic Opioids
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Table one illustrates three different types of fatal opioid overdoses. The first type – and 
the first wave – of overdoses is commonly prescribed opioids. This type of opioid comes in the 
form of prescription medications including methadone, oxycontin, hydrocodone, codeine, etc. A 
drastic increase in the number of opioid prescriptions began during the mid-1990s, and from 
1999 to 2011, consumption of hydrocodone more than doubled and consumption of oxycodone 
increased by nearly 500%. From 1997 to 2011, there was a 900% increase in individuals seeking 
treatment for addiction to opioid pain relievers (Kolodny et al., 2015). The increases in fatal 
prescribed opioid overdoses that are seen from 1999 to 2011 imply the leniency in opioid 
prescribing policies during this time.  
 The next wave of fatal overdoses shown in Table one is from heroin. This dangerous drug 
is more potent than opium or morphine and is often taken intravenously by the user. Beginning 
in 2007, many of the opioid addicted persons in the country found an easier way to achieve their 
high, for a cheaper price. The chart may also imply a disruption in some people’s supply of 
opioid prescriptions. The disruption in their supply may have pushed them to purchase opioids 
from the illegal drug market. Around the time we see an increase in heroin overdoses, the 
government had begun regulating opioid prescribing policies, making the drug difficult to access 
for many already addicted. According to the federal government's National Survey on Drug Use 
and Health (NSDUH), 4 out of 5 current heroin users report that their opioid use began with 
prescription drugs (Muhuri, Gfroerer, & Davies, 2013). In a sample of opioid addicted 
individuals who switched from opioid prescription pills to heroin, 94% reported doing so 
because the pills “were far more expensive and harder to obtain” (Cicero et al., 2014).  
 The final wave of overdoses to discuss involves other synthetic opioids (fentanyl, 
tramadol, etc.). When synthetic opioids were introduced to the drug market around 2013, fatal 
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drug overdoses began to increase more drastically than the country has ever seen before. The 
primary synthetic opioid being cut into heroin is fentanyl, and the drug is 25 to 50 times more 
potent than heroin (Lui, Pei, & Soto, 2018).  The implications from Table one shows the 
increased use of synthetic opioids in the country after the drug was introduced in 2013.  
Monroe County 
Before conducting the analysis, it is important to recognize the importance of the opioid 
epidemic in Monroe County, NY. In 2017, the opioid overdose death rate (per 100,000 
population) in the United States was 14.9. This is a 12% increase from 2016. In the state of New 
York, the opioid overdose death rate is was 16.1. This is higher than the national average and it 
is a 7% increase from the previous year (Kaiser Family Foundation, 2019). In the Western 
district of New York located near the Finger Lakes region, Monroe County’s population is 
almost 750,000 (US Census, 2019).  
Monroe County has experienced the devastation and loss like many other counties 
throughout the United States. In just over three years, the county experienced 2,459 overdoses, 
with 418 of them ending in a fatality. Made up of several towns and the city of Rochester, opioid 
overdoses have occurred in each of these geographic locations in the county, predominantly 
taking place in Rochester. A medium-sized city, Rochester has had an intense difficulty dealing 
with opioid overdoses. Table two illustrates the total number of fatal and non-fatal overdoses in 
Monroe County, sorted by the town or city the overdose occurred in, from January 1st, 2016 to 































*Table created by Abigail Hallowell, Research Assistant with the Center for Public Safety Initiatives (CPSI) 
 
Monroe County had a total of 2,459 overdoses from January 2016 to April 2019. As 
shown in the table, over half over those overdoses (n=1,590) were in the city of Rochester. In the 
chart, it appears residents in the city of Rochester have been impacted by opioid overdoses more 
severely than suburban residents. However, it is important to note that many residents in suburbs 
surrounding the inner-city may likely be traveling into the city to purchase the drugs, and then 
overdosing there. Also, this chart does not consider the rate of overdoses based on population 
size. The population in the city of Rochester is about 208,000 – significantly larger than the 
population any of the towns listed in the chart. These towns likely have lower overdose numbers 
than Rochester because their population is much smaller.  
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The next table worth examining illustrates a breakdown of all opioid overdoses over a 3-
year period. Table 3 contains all fatal and non-fatal opioid overdoses in Monroe County from 
January 2016 to January 2018; 
Table 4. 
 
*Graph created by Abigail Hallowell, Research Assistant with CPSI  
 
In 2016, there were 82 fatal overdoses and 260 non-fatal overdoses. In 2017, the number of fatal 
overdoses almost doubled (n=145), while non-fatal overdoses almost tripled (n=662). In 2018, 
there was a slight increase for fatal overdoses from the previous year (n=145). The same year, a 
similar pattern is reflected with non-fatal overdoses drastically increasing (n=967). The high 
number of fatal and non-fatal overdoses shown in the graph reflect the prominence of opioid 
abuse in Monroe County.  
 Though the total number of fatal opioid overdoses has continued increasing since 2016, 
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were fatal was 24%. In 2017, 17% of opioid overdoses were fatal in Monroe County. This is a 
6% decrease from the previous year. In 2018, after the implementation of Narcan, only 14.6% of 
overdoses in the county were fatal. This is almost a 10% decrease in the percent of fatal 
overdoses since 2016. These results imply that something is being done in the county to decrease 
the percentage of fatal opioid overdoses. It may be due to the implementation of an intervention 
targeted at fighting the opioid problem in Monroe County.  
 
Narcan 
To combat opioid overdoses in the county, local officials in Monroe County began 
responding by offering education, training, and the distribution of Narcan. A medical 
intervention that has become more popular in recent years, the use and distribution of 
Naloxone/Narcan, is intended to reduce fatal opioid overdoses. Narcan is a drug that can 
temporarily reverse the potentially deadly effects of opioid overdose during an emergency. In 
2014, the FDA approved the use of Narcan in an opioid emergency for the general public (Pryor, 
2017). 
  In January 2018, the Monroe County Heroin Task Force was implemented to combat 
opioid overdoses locally. The Heroin Task Force is a collaboration between several government 
and law enforcement agencies in Monroe County that was created in response to the opioid 
epidemic. After implementation of the intervention, the Task Force increased efforts to expand 
the use and distribution of Narcan throughout the county. Also in January 2018, to assist the 
Task Force’s effort in expanding the use of Narcan, the Monroe County Department of Public 
Health claimed it would increase the availability of the drug (Opioid Action Plan, 2019). In 
October 2018, Chief Mark Simmons of the Rochester City Police Department announced that all 
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officers would be equipped with a Narcan kit and be trained on how to administer the drug 
(Simmons, 2018). Table four illustrates the use of Narcan in opioid overdoses in Monroe County 
from 2016 to 2018; 
Table 4. 
 
*Graph created by Abigail Hallowell, Research Assistant with CPSI  
 
  Table four shows an increase in the use of Narcan in Monroe County since 2017. 
Although there was a decrease in use of Narcan in the first half of 2018, this decline is likely 
spurious. The chart shows Narcan use spike back up during the second half of 2018. The 
increased efforts to expand the use and distribution of Narcan is due directly to the drastic 
increase in fatal opioid overdoses in the county. It is important to see the increase in the use of 
Narcan during the past three years because it suggests we may see an improvement in overdoses 
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NARCAN ADMINISTRATION DURING OPIOID 




 This research is intended to analyze what factors, if any, impact if an opioid overdose is 
going to be fatal or not. To do this, I will conduct a secondary-data analysis of opioid overdose 
data in Monroe County, NY from January 1st, 2016 to April 1st, 2019 to determine any 
statistically significant findings (n=2,459). The data set had a total of 103 missing cases within 
the independent and controlled variables. These cases were not included in the analysis or 
logistic regression and our new sample does not include them (n=2,356). Because my dependent 
variable in this experiment is dichotomous, I concluded that a logistical regression is the best 
statistical method to use for this research. Also, due to the nature of studying social sciences and 
specifically fatal opioid overdoses, I determined this the best methodology to achieve the goals 
of this analysis.  
Objectives 
 The main objective of this research is to evaluate factors that contribute to an overdose 
being fatal or non-fatal in Monroe County. As stated earlier, the primary research questions I am 
asking in this study are; 
1. What factors impact if an opioid overdose will be fatal?  
2. Does the administration of Narcan during an overdose decrease the likelihood that an 
overdose will be fatal? 
3. Does having a prior overdose history increase the likelihood that an overdose will be 
fatal? 
I hypothesize that there are outside influences that may significantly impact whether an 
opioid overdose is fatal or not. Specifically, the two hypotheses are; (1) when the administration 
of Narcan in overdoses increases, the likelihood of the overdose being fatal decreases and (2) 
when the victim of the overdose incident has a prior history of overdose, the likelihood of the 
overdose being fatal will increase. I believe hypothesis one to be significant because the 
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reversing effects that Narcan has on a potentially fatal overdose is important. Because Narcan 
can reverse these effects, I believe it will have a significant impact on if an overdose results in a 
fatality or not. Hypothesis two may be important because if someone has a prior history of 
overdosing, that may put them more at risk of having another overdose, this time possibly being 
fatal. It is the goal of this research to answer these questions empirically using the best possible 
methods to determine if there are any significant outcomes.  
Operationalization of Variables  
To empirically asses my hypotheses and research questions, the opioid overdose data has 
been coded to allow a statistical regression analysis to be conducted. To conduct the statistical 
analysis, I will operationalize my variables as follows; 
1. Dependent Variable 
• Fatal overdoses: This variable serves to measure whether an opioid overdose 
resulted in the death of the victim. (1=Yes; 0=No) 
2. Independent Variables 
• Narcan administration: This variable serves to measure if Narcan was 
administered to the victim during the opioid overdose. (1=Yes; 0=No).  
• Prior overdose history: This variable serves to measure if the victim had a history 
of prior overdose. (1=Yes; 0=No) 
3. Controlled Variables  
• Age of victim: This variable controls for the age of the victim during the time of 
the overdose. (0-76 years old) 
• Gender of victim: This variable control for the gender of the victim. (M=1; F=0) 
• Race of victim: This variable controls for the race of the victim. (W=1; NW=0) 
• Ethnicity of victim: This variable controls for the ethnicity of the victim. (H=1; 
NH=0) 
4. ‘Dummy’ Variable 
• Year of overdose: It is important to highlight if the fatal overdose occurred before 
or after the implementation of Narcan in January 2018. (2016-2017=0, 2018-
2019=1). 
Because my sample is of individual opioid overdoses, the unit of analysis is at the individual 
level. My target population addresses individuals who are high-risk opioid users because they 




 With overdose numbers continuing to rise, the Monroe County Heroin Task Force began 
to track opioid overdose data in the county and has maintained a large data set of all reported 
overdoses in Monroe County from January 2016 to April 1st, 2019 (n=2,459). The data set 
contains qualitative information on each overdose victim and the details surrounding the 
overdose. The Task Force works with their partners to attempt to have the local responding 
police officers and Emergency Medical Technicians collect this data at every single overdose 
occurrence in Monroe County. They also work closely with the Monroe County Medical 
Examiner’s office to assemble data on fatal overdoses specifically (Monroe County Heroin Task 
Force, 2018).  
The Task Force’s data was retrieved from the Monroe Crime Analysis Center (MCAC), 
an organization that works closely with the Center for Public Safety Initiatives (CPSI) at the 
Rochester Institute of Technology. Because the data is confidential, I only gained access to it 
through my employment with CPSI. Using this data, I will conduct a secondary-data analysis and 
a logistical regression to determine if there are any statistically significant factors that are 
impacting fatal opioid overdoses.  
 
Descriptive Statistics 
 It is important to review the description of each variable in the study prior to analyzing 
any findings. As stated earlier, to combat issues with internal validity, each variable within the 
data set was examined and cleaned for missing cases. I also performed a cross tabulations 
analysis of Narcan administration on fatal overdoses that is included in this section. The 




   Table 5.  
Variable Percent Yes Percent No # Missing Cases 
Fatal 17% 
(n=1,955) 
83% (n=401) 0 
Narcan Administered 70.6% 29.4% 44 
Prior OD History 69.4% 30.6% 37 
 
Fatal Overdoses 
I will first analyze the dependent variable in the study, fatal opioid overdoses. Within the 
total opioid overdoses in the sample for our study (n=2,356), fatal and non-fatal overdoses were 
both included. In Monroe County from January 2016 to April 2019, 83% of opioid overdoses 
were non-fatal (n=2,041). The remaining 17% of opioid overdoses resulted in a fatality (n=418). 
There were no missing cases within the dependent variable.  
Narcan Administration 
 As shown in Table five, Narcan was administered 70.6% of the time (n=1,736). The drug 
was not administered in 27.6% of the overdoses (n=679). In the Narcan variable, after cleaning 
the data there were 44 missing cases, 31 were recorded as “unknown” and 13 were recorded as 
blanks. When the case is recorded “unknown”, we cannot include that case within our sample 
because assuming the victim was or was not administered Narcan may lead to statistical 
inaccuracy in the findings of this study.  
The overdoses in the sample that had Narcan administered (n=1,736), resulted in a 
fatality 5.7% of the time (n=94). The overdoses within the sample that did not have Narcan 
administered (n=679) resulted in a fatality almost half of the time (46.8%) (n=318). After a cross 
tabulations analysis of Narcan and the dependent variable, there were some significant results. 
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The analysis found that when Narcan is administered, the overdose is 94.6% more likely to be 
non-fatal. Thus, when Narcan is administered, there is only a 5.4% chance of the overdose 
resulting in a fatality. When not administered, there is a 46.8% chance that the overdose will 
result in a fatality. These findings are statistically significant (p=.000).  
 Victim Prior Overdose History 
This analysis includes prior overdose history of each overdose victim within our sample. 
In the sample, 69.4% of the overdoses did not have a victim with a prior overdose history 
(n=1,682). However, 30.6% of the overdoses contained a victim who had a record of a prior 
overdose history (n=740). There were 36 missing cases within this variable.  
Victim Gender 
 The first controlled variable to discuss is the gender of the victim in each overdose within 
the sample. Out of the total overdoses in Monroe County in our sample, 72% of the overdose 
victims were male (n=1,760) and 28% of them were female (n=699). There were no missing 
cases within this variable.  
Victim Race and Ethnicity 
For the race and ethnicity variables in the study, 91% of the victims in each overdose in 
our sample were white (n=2,211). The other 9% of the sample identified as non-white (n=266). It 
is also important to analyze the ethnicity of the victim when analyzing their race. 87% of 
overdose victims are non-Hispanic (n=2,134) and 13% of victims identified as Hispanic (n=313). 
Race and ethnicity of the victim were the two controlled variables that also had missing cases 
that were excluded from the analysis. Race contained 11 missing cases and ethnicity contained 





 The final variable controlled for in the study, the victim’s age, had some interesting 
findings. The median of ages is the sample was just below the mean at 33 years old. The mode, 
or most repeated age in the sample, is 27 years old. The mean age of overdose victims in the 
sample was 35.6 years old. However, there are outliers within the data set when discussing the 
median age that are important to highlight.  
The oldest age of the victim was 76 years old, and the youngest was 0 years old (9 
months old). This case – and one other where the victim was 1 year old – throw off the average 
age due to the dissimilar nature of these two overdoses. The two overdose cases are likely due to 
an infant somehow accidently accessing their parent/guardian’s supply of opioids and ingesting 
it. There was a case in Monroe County in 2018 of a 9-month old infant overdosing on their 
parent’s illegal opioid drug. The mother and grandparents of the child were all charged with 




 The logistic regression that was conducted for this study uses an odds ratio to determine 
the odds of a fatal overdose being more or less likely when the independent variables are present. 
Based on the results of the analysis, I found that in Monroe County, NY, the administration of 
Narcan did have a significant impact on fatal overdoses in Monroe County. The analysis also 
revealed a significant impact of victim age on fatal overdoses. This allowed us to reject the null 
hypothesis in hypothesis one. However, the analysis found there were no statistically significant 
impacts of victim prior overdose history on fatal overdoses in Monroe County. We accept the 
null hypothesis of hypothesis two. The analysis also revealed a significant impact of victim age 
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on fatal overdoses. There were no other significant findings from the remaining variables that 
were included in the study. Table six summarizes the findings of the logistic regression; 
Table 6. 
Logistic Regression Analysis of Variables – Odds Ratio 
 B S.E. Wald df Sig. Exp. (B) 
Narcan Administered -2.683 .134 401.924 1 .000 .068 
Prior OD History -.237 .145 2.695 1 .101 .789 
Victim Ethnicity -.167 .206 .655 1 .418 .846 
Victim Race .120 .226 .282 1 .595 1.128 
Victim Gender -.153 .143 1.137 1 .286 .858 
Victim Age .022 .005 15.976 1 .000 1.022 
Year -.131 .076 2.963 1 .085 .877 
Constant 263.524 153.511 2.943 1 .086 2800E+114 
    *Variable(s) entered: Narcan Administered, Victim Gender, Victim Race, Prior OD History, Victim Ethnicity, Year, Victim Age. 
 
Table six represents the logistic regression analysis using an odds ratio. The Exp.(B) 
column represents the odds. The table illustrates that when controlling for victim gender, victim 
race, victim ethnicity, and victim age, the odds of an overdose being fatal are expected to be 0.68 
time less when Narcan is administered. This finding is statistically significant (p=.000). We can 
reject null hypothesis one. When controlling for those same variables, the regression found there 
were no significant increases or decreases in odds of an overdose being fatal for prior overdose 
history, victim race, victim ethnicity, victim gender, or year of overdose. We fail to reject null 
hypothesis two. However, the regression determined that as the victim’s age increases, the odds 
of an overdose being fatal are expected to increase by 1.02. This unexpected finding is 






Implications and Recommendations  
 The implications that can be drawn from the findings are extensive, and they are all 
essential to discuss when addressing how to best combat the opioid epidemic. The analysis 
revealed some interesting implications that can be made regarding the outcomes of each 
hypotheses of the study. For my first hypothesis, the outcomes indicate significant positive 
impacts that the administration of Narcan during an overdose emergency has on fatal overdoses. 
This implies the success of Narcan in combating the opioid epidemic in Monroe County. The 
results also imply that Narcan may be the reason the percent of fatal overdoses have been 
decreasing in the county (shown in Table 3). The use and distribution of Narcan should continue 
and the Heroin Task Force and their partners should continue the increased expansion of the drug 
throughout the county. 
To continue researching the impacts of Narcan in the county it would be helpful to begin 
recording the time of the overdose versus the time Narcan was administered. There may be a 
significance in how long the victim has to wait after they overdose before they receive Narcan. It 
may also be important to collect data on who administers the Narcan (person with victim during 
time of overdose, EMT, law enforcement officer, hospital staff member, etc.) to look for any 
significant differences in fatal overdoses based on this variable.  
Our second hypothesis was incorrect, finding no significance of the victim having a prior 
overdose history. There are several possible implications regarding this finding. First, it implies 
that overdosing in the past does not have an impact on future overdoses being fatal or non-fatal. 
It may also imply that people who have a history of overdosing are prepared for an overdose 
occurrence and may have Narcan available. Data should continue to be collected on this variable, 
and in further detail, similar to Narcan. The number of prior overdoses a victim has had and if 
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the person received Narcan during their prior overdoses may both be important pieces of 
information when assessing this variable. This may lead to further implications on Narcan 
administration. It would also help determine if the number of a victim’s previous overdoses 
impacts the odds of an overdose being fatal.  
An important finding, as age increases odds of an overdose being fatal increase, has a few 
indications for the opioid epidemic. This may imply that the wear and tear abusing opioids does 
to the body may be more difficult for an older person to handle. They may have other existing 
health issues that derive from aging that opioid use effects. Another implication from this 
outcome may be that an older person likely has been using opioids for longer, and has had more 
damage done to their body, and has a less likely chance of surviving future overdoses. This 
finding and its implications are grim. Scientific and medical analyses should be conducted on 
this topic to further knowledge on how age impacts fatal overdoses.  
Another interesting aspect of our data to discuss is the disparities in the race of overdose 
victims in our sample. There were no statistically significant findings on race impacting fatal 
overdoses. As stated earlier, 91% of the overdose victims are white and 9% of them are non-
white. Non-white can consist of Black, Asian, Native American, etc. In table two earlier in the 
paper, we see that the most overdoses in the county are occurring within the city of Rochester. 
The city of Rochester has a population of about 208,000 people. According to the US Census, 
40.7% of the city’s population identified as Black or African American as of July 2018. This 
percent along with the predominant rate of overdoses occurring within the city limits would 
suggest that there would be more overdoses with Black victims. The low percentage of black 
victims in the sample implies there is a reason that Black residents of Rochester’s inner-city are 
not using opioids as much as whites. Researchers can continue to speculate on the different 
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theories behinds this, possibly looking into how Black Americans history and experiences with 
drugs and the US government may have impacted their use of opioids today. 
Lastly, the findings on the year of the overdose variable was of little surprise. Although 
Narcan was officially implemented in Monroe County in January 2018, the drug has been around 
to reverse overdose effects for a while. Monroe County was already using Narcan in 2016 and 
2017 to treat opioid overdoses. Due to this, there was no significant differences within fatal 
overdoses based on if the overdose occurred before or after January 2018.  
 
Limitations 
Because of time and resource restrictions of this study, an analysis of secondary data was 
the best method to use when addressing my research questions. There are multiple challenges 
that are faced when conducting a secondary-data analysis, and there are unique issues when 
dealing with secondary overdose data. For example, there may be several non-fatal overdoses in 
the area that were not recorded because 911 was never called. The nature of opioid use is illegal 
and private, and we cannot be sure how many overdoses in the county were missed in our 
sample. Although missing these overdoses is a limitation of the study, a sample of over 2,000 
overdose cases was enough to conduct an empirical analysis with accurate findings.  
The Monroe County Heroin Task Force began in 2018 and retrieves their data from 
different agencies like local police departments, public health agencies, EMT companies, etc. 
The different agencies may not record the same number of overdoses, or the responders may not 
record all necessary information (i.e. Narcan administration, prior overdose history, etc.). These 




Another limitation in our sample is within the race and ethnicity variables. Rochester, NY 
has a large Puerto Rican population, many of which identify as Hispanic. However, some may 
identify as white or other. Also, many victims who identified as Hispanic (Y=1) were also 
recorded in the data set as white (W=1) and this may give inaccuracy to our race variable. The 
issues with recording these variables in certain cases in our sample may give inaccurate findings 
on the outcomes of race and ethnicity in our logistic regression. 
Often in social and criminal justice agencies, data is not accurately recorded or may not 
be being recorded at all. An example of this can be found in the inconsistencies within crime 
statistics from the FBI’S Uniform Crime Report (UCR). The UCR often underreports on data 
due to how the data are being collected. The UCR retrieves its information from police agencies 
around the country, neglecting issues such as crimes that go unreported to the police or crimes 
that do not result in an arrest (Pepper and Petrie, 2003). To highlight possible issues with internal 
validity in our study, I will use an example directly from the Monroe County Heroin Task Force.  
There are discrepancies in the numbers of opioid overdoses that Monroe County has 
recorded that can be found online. The Monroe County Heroin Task Force contradicts 
themselves in some of their data that they offer to the public. The Opioid Action Plan, created by 
a few main members of the Heroin Task Force, offers opioid overdoses data for Monroe County 
on its website. On the Opioid Action Plan’s website, the opioid overdose data they list for 2016 
and 2017 does not match the data from the Heroin Task Force’s website. The discrepancies are 





*Source: Monroe County Medical Examiner’s Office & NYS Department of Health Quarterly Opioid County Report. 
  
Table seven illustrates that in 2016 Fatal Overdoses, the difference between numbers for 
the Task Force and the Action Plan was only (+/-) 10 (n=169, n=159). However, in every other 
variable there is a difference of at least (+/-) 80 overdoses between the two agency’s recordings. 
The Opioid Action Plan is part of the Task Force, yet they still do not have the same overdose 
numbers. It is worth noting that in 2016 and 2017, before the formation of the Monroe County 
Heroin Task Force, it is possible that there is some inaccuracy in undercounting overdoses within 
the data. Local officials had not yet implemented the Monroe County Heroin Task Force, 
requiring the precise tracking and recording of opioid overdoses. Thus, the numbers of overdoses 
that we have for those years should be met with skepticism, as they may be higher than what was 
documented. The purpose of the graph is to highlight possible challenges with internal validity in 
the sample. It is extremely important that government agencies continue to work together to 
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 The opioid epidemic in Monroe County is a continuing issue, and the use and distribution 
of Narcan has been a leading intervention to try and combat it. By analyzing opioid overdoses in 
the county, a more empirical understand of fatal overdoses can be achieved. The effectiveness of 
Narcan is an imperative finding, and the outcomes of the other variables are just significant. The 
findings of the analysis will likely lead most to formulate more questions about the opioid 
epidemic and how to stop it. Although there are limitations to the outcomes of this study, the 
information presented is important so other researchers can continue the research that has been 
started. It would be useful for more empirical analyses of opioid overdose data to be done so 
more accurate conclusions can be drawn regarding how to best fight against the opioid crisis in 
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